Table 2.
Comparison of lab tests and CT scan of COVID-19 in children and adults
| Median (IQR) | |||||
|---|---|---|---|---|---|
| Normal range | Total (N = 67) | Children (n = 14) | Adults (n = 53) | p | |
| WBC (× 109/L) | 4–10 | 5.33 ± 1.84 | 5.93 ± 2.52 | 5.17 ± 1.60 | 0.30 |
| Decreased | 4 (28.6%) | 10 (18.9%) | 0.61 | ||
| N (× 109/L) | 2–7 | 2.88 ± 1.45 | 1.76 ± 0.53 | 3.18 ± 1.45 | 0.00 |
| Decreased | 9 (0%) | 6 (11.3%) | 0.00 | ||
| L (× 109/L) | 0.8–4 | 2.02 ± 1.36 | 3.68 ± 2.04 | 1.57 ± 0.59 | 0.00 |
| Decreased | 1 (7.1%) | 5 (9.4%) | 0.79 | ||
| M (× 109/L) | 0.12–0.8 | 0.36 ± 0.15 | 0.36 ± 0.11 | 0.36 ± 0.16 | 0.95 |
| Increased | 0 (0%) | (0%) | |||
| HBG (g/L) | 110–150 | 137.3 ± 20.02 | 131.64 ± 12.92 | 138.83 ± 21.38 | 0.12 |
| Increased | 1 (7.1%) | 2(2.8%) | 0.08 | ||
| PLT (× 109/L) | 100–300 | 213.4 ± 64.62 | 243.79 ± 76.16 | 205.29 ± 59.36 | 0.047 |
| Increased | 2 (14.3%) | 2 (2.8%) | 0.14 | ||
| CRP (mg/L) | 0.068–8.2 | 9.05 ± 15.81 | 1.26 ± 2.82 | 11.19 ± 17.21 | 0.00 |
| Increased | 1 (7.1%) | 18 (34%) | 0.048 | ||
| PCT (µg/L) | 0–0.05 | 0.05 ± 0.05 | 0.05 ± 0.02 | 0.05 ± 0.06 | 0.83 |
| Increased | 5 (35.7%) | 13 (24.5%) | 0.40 | ||
| LDH (U/L) | 109–245 | 222.6 ± 71.68 | 298.63 ± 92.95 | 205.57 ± 53.80 | 0.01 |
| Increased | 7 (50%) | 10 (18.9%) | 0.02 | ||
| CK (U/L) | 26–140 | 94.38 ± 57.11 | 107.54 ± 44.70 | 91.08 ± 59.73 | 0.36 |
| Increased | 4 (28.6%) | 8 (15.1%) | 0.24 | ||
| Myo (µg/L) | 10–46 | 18.84 ± 11.61 | 15.33 ± 7.92 | 19.50 ± 12.13 | 0.33 |
| Increased | 0 (0%) | 2 (3.8%) | 0.46 | ||
| Ctn (µg/L) | 0–0.01 | 0.01 ± 0.00 | 0.01 ± 0.00 | 0.01 ± 0.00 | 0.68 |
| Increased | 0 (0%) | 0 (0%) | |||
| BUN (mmol/L) | 2.9–8.2 | 4.07 ± 1.21 | 4.23 ± 1.12 | 4.03 ± 1.24 | 0.58 |
| Increased | 0 (0%) | 1 (1.9%) | 0.61 | ||
| Cr (µmol/L) | 50.4–98.1 | 59.80 ± 14.29 | 43.08 ± 11.20 | 64.30 ± 11.44 | 0.00 |
| Increased | 0 (0%) | 0 (0%) | |||
| PT (s) | 8.8–13.8 | 12.61 ± 0.99 | 12.53 ± 0.89 | 12.63 ± 1.01 | 0.75 |
| Increased | 1 (7.1%) | 7 (13.2%) | 0.53 | ||
| D-dimer (µg/ml) | 0–0.5 | 0.49 ± 0.37 | 0.47 ± 0.26 | 0.50 ± 0.40 | 0.82 |
| Increased | 5 (35.7%) | 19 (35.8%) | 0.99 | ||
| ALT (U/L) | − 0–40 | 28.42 ± 28.31 | 21.29 ± 29.18 | 30.35 ± 28.05 | 0.29 |
| Increased | 1 (7.1%) | 9 (17%) | 0.36 | ||
| AST (U/L) | 0–40 | 25.47 ± 12.77 | 29.00 ± 8.84 | 24.52 ± 13.54 | 0.25 |
| Increased | 1 (7.1%) | 7 (13.2%) | 0.96 | ||
| IL-6 (pg/ml) | 0–7 | 7.94 ± 12.98 | 2.50 ± 2.83 | 9.16 ± 14.04 | 0.01 |
| Increased | 1 (7.1%) | 4 (7.5%) | 0.24 | ||
| Lung injury | 56 | 11 (78.6%) | 45 (84.9%) | 0.57 | |
| CT (bilateral) | 36 | 6 (54.5%) | 30 (66.7%) | 0.45 | |
| CT (unilateral) | 20 | 5 (45.5%) | 15 (33.3%) | ||